國立虎尾科技大學 |

Antidepressants = from biogenic amine to new mechanisms of action /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Antidepressants/ edited by Matthew Macaluso, Sheldon H. Preskorn.
Reminder of title:	from biogenic amine to new mechanisms of action /
other author:	Macaluso, Matthew.
Published:	Cham :Springer International Publishing : : 2019.,
Description:	xii, 442 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Antidepressants. -
Online resource:	https://doi.org/10.1007/978-3-030-10949-3
ISBN:	9783030109493

Antidepressants = from biogenic amine to new mechanisms of action /
Antidepressantsfrom biogenic amine to new mechanisms of action /[electronic resource] :edited by Matthew Macaluso, Sheldon H. Preskorn. - Cham :Springer International Publishing :2019. - xii, 442 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2500171-2004 ;. - Handbook of experimental pharmacology ;v.212..

Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past - from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression.

This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.

ISBN: 9783030109493

Standard No.: 10.1007/978-3-030-10949-3doiSubjects--Topical Terms:

783739
Antidepressants.

LC Class. No.: RM332 / .A58 2019

Dewey Class. No.: 615.78

Antidepressants = from biogenic amine to new mechanisms of action /
LDR:02523nam a2200337 a 4500 001 940191
003 DE-He213
005 20191016165502.0
006 m d
007 cr nn 008maaau
008 200417s2019 gw s 0 eng d
020 $a 9783030109493 $q (electronic bk.)
020 $a 9783030109486 $q (paper)
024 7 $a 10.1007/978-3-030-10949-3 $2 doi
035 $a 978-3-030-10949-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RM332 $b .A58 2019
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.78 $2 23
090 $a RM332 $b .A629 2019
245 0 0 $a Antidepressants $h [electronic resource] : $b from biogenic amine to new mechanisms of action / $c edited by Matthew Macaluso, Sheldon H. Preskorn.
260 $a Cham : $c 2019. $b Springer International Publishing : $b Imprint: Springer,
300 $a xii, 442 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.250
505 0 $a Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past - from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression.
520 $a This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.
650 0 $a Antidepressants. $3 783739
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Psychopharmacology. $3 644799
650 2 4 $a Neurosciences. $3 593561
700 1 $a Macaluso, Matthew. $3 1226711
700 1 $a Preskorn, Sheldon H. $3 1226712
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v v.212. $3 882814
856 4 0 $u https://doi.org/10.1007/978-3-030-10949-3
950 $a Biomedical and Life Sciences (Springer-11642)